Potent inhibition of genital herpesvirus infection in goats by cidofovir.
Canio Buonavoglia , Vito Martella , Elvira Tarsitano , Nicola Decaro
Antiviral Therapy 12 ( 6) 977 -979
10
2007
Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutants.
Fabien Zoulim , Lieve Naesens , Christian Pichoud , Bettina Werle-Lapostolle
Antiviral Therapy 13 ( 3) 381 -388
39
2008
Kinetic, mechanistic and chemodynamic characterisation of non-nucleoside hepatitis C virus NS5B polymerase inhibitors using SPR biosensor technology
Jan Paeshuyse , Gerhard Puerstinger , Ralf Bartenschlager , Johan Neyts
1
2009
Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovir.
Graciela Andrei , Johan Neyts , Erik De Clercq , Sandra Liekens
Cancer Research 58 ( 12) 2562 -2567
34
1998
Inhibition of Fibroblast Growth Factor-2-induced Vascular Tumor Formation by the Acyclic Nucleoside Phosphonate Cidofovir
Domenico Ribatti , Erik Verbeken , Johan Neyts , Marco Presta
Cancer Research 61 ( 13) 5057 -5064
39
2001
Rodent models for the study of therapy against flavivirus infections
Pieter Leyssen , Nathalie Charlier , Johan Neyts , Erik De Clercq
Antiviral Research 63 ( 2) 67 -77
22
2004
Carrier-Mediated Delivery Improves the Efficacy of 9-(2-Phosphonylmethoxyethyl)Adenine against Hepatitis B Virus
Martin K. Bijsterbosch , Remco L. A. de Vrueh , Theo J. C. van Berkel , Johan Neyts
Molecular Pharmacology 60 ( 3) 521 -527
13
2001
Bacterial artificial chromosomes
Johan Neyts , Kai Dallmeier
15
2014
Anti-Coxsackievirus B activity of 2-(3,4-dichlorophenoxy)-5-nitrobenzonitrile analogues
G Pürstinger , Johan Neyts , Erik De Clercq , Armando De Palma
Antiviral Research 65 ( 3)
2005
New treatment strategies for dengue and other flaviviral diseases
Nathalie Charlier , Johan Neyts , Erik De Clercq
Novartis Foundation symposium 277 217 -231
1
2006
∆F13L-GFP-Vac (p37-deleted vaccinia virus) is attenuated in mice and protects against infection with wild-type virus
Dennis Hruby , Johan Neyts , Robert Jordan , Erik De Clercq
Antiviral Research 70 95
2006
Hepatitis C virus (HCV) proteins stimulate the expression of pro-angiogenic factors in hepatocellular carcinoma cells
Jan Paeshuyse , Johan Neyts , Sandra Liekens , Ben Verpaalen
Angiogenesis 17 ( 3) 747 -747
2014
Novel strategies for the treatment of infections with the hepatitis C virus
Lotte Coelmont , Leen Delang , Johan Neyts
2010
Effect of Hepatitis B virus replication on oxidative stress, gene expression and induction of genetic changes in an inducible cell culture model of HepAD38 cells
Marcel Zeegers , Tamara Severi , Johan Neyts , Alfons Van Lommel
Journal of Hepatology 42 133 -134
2005
u-PA-Gene Inactivation or TIMP-1-Gene Transfer Impairs Cardiac Injury Caused by Viral Myocarditis in Mice
Stephane Heymans , Peter Carmeliet , Johan Neyts , Frans Van de Werf
Circulation 106 ( 19)
2002
Differential anti-HBV activity in vitro of three potent inhibitors of inosine monophosphate dehydrogenase: Mycophenolic acid 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) and ribavirin
Johan Neyts , ZJ Gong , Erik De Clercq , S De Meyer
Hepatology 28 ( 4)
1998
Mycophenolic acid, an immunosuppressive agent, inhibits replication in cultures of primary an immortalized human hepatocytes
Johan Neyts , ZJ Gong , Erik De Clercq , Sing Hiem Yap
Hepatology 26 ( 4) 389 -389
3
1997
The influence of cyclosporin and corticosteroids on HBV replication in primary cultures of human hepatocytes
Johan Neyts , ZJ Gong , Erik De Clercq , S De Meyer
Hepatology 28 ( 4)
1998
Activity of 7,8-dihydro-isoquinoline-6-carboxylic acid [2-(1H-indol-3-yl)-ethyl]-amide hydrochloride salt against human cytomegalovirus (HCMV)
Dirk Daelemans , Robert Snoeck , Graciela Andrei , Johan Neyts
Antiviral Research 53
2002